Mats Jerkeman
71 – 80 of 202
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
- Contribution to journal › Article
-
Mark
Detecting deviations from the efficacy and safety results of single-arm trials using real-world data : The case of a CAR-T cell therapy in B-cell lymphoma
(2021) In Pharmacoepidemiology and Drug Safety
- Contribution to journal › Article
-
Mark
Newly diagnosed and relapsed follicular lymphoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
(2021) In Annals of oncology : official journal of the European Society for Medical Oncology 32(3). p.298-308
- Contribution to journal › Article
- 2020
-
Mark
National e-library for standardized chemotherapy regimens
- Contribution to journal › Letter
-
Mark
Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL
- Contribution to journal › Letter
-
Mark
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma
- Contribution to journal › Article
-
Mark
Healthy lifestyle and the risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition study
- Contribution to journal › Article
-
Mark
p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma
- Contribution to journal › Article
-
Mark
Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century – a Swedish lymphoma register study
- Contribution to journal › Article
-
Mark
Detection of HPV mRNA in Self-collected Vaginal Samples Among Urban Ethiopian Women
- Contribution to journal › Article
